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ABSTRACT 
A systematic review with meta-analysis was carried out to investigate the effects of 
increased nutritional intake, via either macronutrient or multi-nutrient intervention, during the 
neonatal period on neurodevelopmental outcomes in infants born at <32 weeks of gestation 
or weighing <1501g at birth.  
Conclusion: Although the relationship remains unclear, increased early nutrition may 
reduce neurodevelopmental impairment in this group of infants. Future research should 












This article is protected by copyright. All rights reserved. 
Key notes  
• Increased early enteral nutrition may reduce neurodevelopmental impairment in very 
preterm and/or very low birth weight infants, but the direct relationship between 
neurodevelopmental outcome and nutrition remains unclear 
• There is a lack of recent adequately powered studies on this topic 
• Additional research is required and should focus on using standardised nutritional 
interventions and an agreed neurodevelopmental assessment battery, as the lack of 
homogeneity was a major limitation in this review 
 
Adverse neurodevelopmental outcome is common in very preterm (VP) and very low birth 
weight (VLBW) infants(1, 2). Postnatal growth failure is also common in these infants(3). 
Epidemiological studies(4, 5) have shown that infants born extremely preterm are often 
lighter and have a smaller head circumference compared with published population norms at 
expected delivery date, despite being born with average weight and head circumference for 
their gestation. Neurodevelopmental outcomes of preterm infants are subject to multiple 
influences and it is likely that nutrition plays a key part. Furthermore, nutrition can be 
measured and modified, and so offers a potential intervention to improve outcomes. At the 
same time, it should be acknowledged that altering early nutrition in preterm infants could 
potentially result in changes to body composition and in turn the risk of obesity and non-
communicable disease in later life(6). Although there is evidence that in VLBW infants poor 
growth during the early postnatal period is associated with a higher incidence of 
neurodevelopmental impairment at toddler age(7), the findings of studies that have 
investigated the effect of early and/or increased nutrition in preterm infants have been 
inconsistent(8-10), and the evidence for nutritional interventions to improve 
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examine the effects of increased early nutritional intake on neurodevelopmental outcomes in 
infants born VP and/or with VLBW assessed at toddler age or during childhood.  
 
METHOD 
Study design  
Studies were considered if they were randomised controlled trials (RCT), non-randomised 
control trials (NRCT), or observational studies. There were no restrictions on publication 
status, language, or year of publication. 
Inclusion criteria  
Studies that specifically compared an intervention providing increased nutrient intakes 
during the neonatal period (defined as first 28 days after birth) in infants born VP, <32 weeks 
of gestational age (GA), or with birth weight (BW) <1501g, with a control group receiving a 
‘standard’ amount of nutrition, were eligible for inclusion. The intervention had to include 
higher quantity of nutrients over a defined period, such as consistently higher nutrient 
intakes in the intervention group compared to the control group, a difference in the increment 
of nutrient increase during the intervention period, or a difference in the length of intervention 
to provide a higher amount of nutrition overall. Nutritional interventions could be parenteral 
nutrition (PN), enteral nutrition (EN), or a combination of both. Studies were excluded if there 
was no documented protocol to increase nutrient intake, or if they focused on one single 
specific micronutrient.  
Outcome measures 
Outcome measures included neurodevelopmental outcome at 12-18 months, 24 months of 
corrected gestational age (CGA) (these ages of assessment hereafter referred to as toddler 
age) and/or at childhood as well as neurological status (presence or absence of Cerebral 
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Index (PDI) subscales of the Bayley Scales of Infant Development Second edition(11) 
(BSIDII) are widely used, meta-analyses were based on these subscales. Studies that 
reported cognitive, language and motor subscales of Bayley Scales of Infant and Toddler 
Development Third edition(12) (Bayley III), were converted into MDI and PDI using Moore et 
al’s method(13) to allow meta-analyses. 
Searches and information source 
A search was carried out by using the search strategy detailed in table 1. The electronic 
databases MEDLINE, EMBASE and CINAHL were searched, with the last search carried out 
on 15th Jan 2015. Conference abstracts and other citations were identified using Web of 
Science. Reference searching was performed on articles that were selected for review.  
Study selection  
Studies were assessed for eligibility by two reviewers (SC and MJ) independently. Selection 
was on the basis of titles and abstracts where possible, with the full text obtained where 
necessary.  
Data collection process 
Data on study characteristics, nutritional interventions, nutritional intakes, and outcome 
measures (neurodevelopmental outcomes, morbidity and mortality) were collected using a 
study specific spreadsheet. Additional data were obtained from authors where required.  
Risk of bias assessment  
The quality of RCT and NRCT was assessed using the Cochrane Risk of Bias Assessment 
Tool(14), and observational studies were assessed using the Newcastle Ottawa Scale(15). 
Synthesis of results   
Parenteral nutrition and EN studies were analysed separately due to their relative timing of 
use during the neonatal period. Meta-analyses were performed where appropriate. Analysis 
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using I2 statistic. A random effects model was used for all continuous data analyses. Peto’s 
method was used to calculate a pooled odds ratio (OR) for binary outcome data(17). When 
means and standard deviations (SD) were not provided, they were calculated using the 
method described by Hozo et al(18). Meta-regression was carried out using Stata version 




The review process is demonstrated in figure 1. Eighteen papers, published between 1982 
and 2014 that reported 15 studies, were included (10 RCT, 1 NRCT, and 4 retrospective 
observational studies). Three of the included studies reported follow-up findings from two 
RCTs. 
Study characteristics  
Characteristics of included studies are summarised in table 2. There were no significant 
differences in the mean±SD of GA (29.6±1.7 vs 29.6± 1.8 weeks, p= 0.80) or birth weight 
(1226.8±321g vs 1234.7±322g, p= 0.60) between the intervention and the control groups. 
Interventions varied between studies; five of the six PN trials investigated early delivery and 
increased content of protein (19-23), the remaining PN trial investigated increases in both 
micro- and macronutrients (24). Four of the seven EN studies investigated multi-nutrient 
supplementation to either maternal or donor breast milk(8-10, 25-28), two studies 
investigated protein supplementation to breast milk(29, 30), and one study compared protein 
enriched formula to standard formula(31). In addition to supplementation, Lucas et al also 
conducted trials that compared multi-nutrient enriched sole diet, containing preterm formula 
only, to either only donor breast milk(9) or only term formula(10), these intervention hereafter 
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Tan et al(32) investigated the effect of hyperalimentation, where the intervention group 
received parenteral or/and enteral nutrition that contained macronutrients above the 
recommended amount, whereas Rochow et al(22) investigated the implementation of a 
feeding program.  
 
Quality assessment 
Assessments of quality and risk of bias in the controlled trials and observational studies are 
summarised in table 3A and 3B respectively. The potential risk of bias in studies was taken 
into consideration during data interpretation. Observational studies were presented 
separately to RCTs and NRCTs in meta-analyses. Of the four observational studies, only 
two studies (21, 24) adjusted for morbidities in their analysis. This is also shown in table 3B.  
Primary outcomes 
Neurodevelopmental outcome  
Neurodevelopmental outcomes were reported in all included studies. Mental Developmental 
Index and PDI were reported in ten studies(8, 10, 19-21, 23, 26, 28, 30, 32). Knobloch et al’s 
Developmental Inventory Quotients(33) were further reported in two studies(8, 9). Two 
studies reported subscales of Bayley III(24, 34). Cormack et al(24) reported scores on 
cognitive, language, and motor subscales which were also converted into MDI and PDI, and 
Burattini et al(34) reported Bayley III scores, but lack of details regarding individual 
subscales meant that MDI could not be calculated. Studies that reported MDI, PDI, or Bayley 
III subscales that allowed conversion to MDI at 12 to 18 months, were included in the meta-
analysis.  Other methods used to investigate neurodevelopment at toddler age included the 
Munich Functional Developmental Diagnostics(35) (MFED) test reported by Rochow et 
al(22), and the Griffiths Mental Development Scales(36) (GMDS) used by Biasini et al(29). 
Studies that investigated neurodevelopmental outcome in childhood and adolescence 
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Intelligence Quotient (FSIQ) using either Wechsler Intelligence Scale for Children (revised 
anglicised version: WISCR- UK)(37, 38), or Wechsler Intelligence Scale for Children-Third 
edition (WISC-III)(39) or Wechsler Adult Intelligence Scale- Revised(WAIS-R)(25, 40).  
Neurodevelopmental outcome at age 12–18 months: Results of meta-analysis  
Meta-analysis of EN trials (8, 10, 26, 28, 30), PN trials (19-21, 24) and two sole diet trials(10, 
28) showed non-significant effects on MDI and PDI. A negative mean difference was 
observed in the meta-analysis of PN studies and MDI (figure 2), and although this was not 
statistically significant, this finding is consistent with meta-analysis at 24 months (figure 5). 
Significant heterogeneity was found in PDI in the meta-analysis of EN trials (I2 = 95%, 
p<0.001) and sole diet trials (I2 = 90%, p<0.001), demonstrated in figure 3 and figure 4, 
respectively. 
Neurodevelopmental outcome at age 12-18 months: Results of meta-regression 
The relationship between early increased nutrition and neurodevelopmental outcome was 
further explored using meta-regression. Energy and protein were considered separately. 
There were no significant linear relationships between energy or protein and MDI or PDI for 
studies using PN. For EN studies, there was no significant linear relationship between 
protein or energy content and MDI at 12-18 months (regression coefficients 1.62 and -0.09 
respectively, p > 0.5 for both). While there was no significant linear relationship between 
increased EN protein and PDI (regression coefficient -30.20, p = 0.33) there was a positive 
linear correlation between energy and PDI that approached significance (regression 
coefficient 0.75, 95% CI: -0.05, 1.54, p = 0.06). Although not statistically significant, this 
suggests that for every extra calorie per kg per day of enteral energy intake, there may be a 
0.75 point increase in PDI. 
Neurodevelopmental outcome at age 24 months: Results of meta-analysis 
Three PN studies(19, 23, 34) reported neurodevelopmental outcomes at 24 months; only 
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only cognitive scales, and therefore MDI and PDI could not be calculated. Whilst Blanco et 
al(19) reported MDI and PDI at both 18 and 24 months, results were pooled into two 
different meta-analyses. The meta-analyses showed that increase in PN has a significant 
negative effect on MDI with a mean difference of -3.99 [(CI 95%, -7.69 to -0.29), p = 0.03], 
but with no significant effect on PDI at 24 months (figure 5A and B). 
Neurodevelopmental outcome: Results not included in meta-analysis 
Tan et al(32) and Rochow et al(22) investigated increasing both EN and PN, and neither 
study reported significant effects on neurodevelopment at 3 and 9 months, or at 24 months, 
respectively.  
Similarly, Burattini et al(34) found no significant differences in Bayley III scores at 24 months 
between infants who received increased amino acid intake and those who received standard 
amount from birth to day four. 
Two EN studies that investigated increasing protein showed contrasting results(29, 31), 
Svenningsen et al(31) reported no group differences in neurodevelopmental outcomes at 
two years of age, whereas Basini et al(29) found that infants receiving additional protein 
performed better in the items of the GMDS at three months CGA (95.5 vs 109.8, p = 0.04). 
Long term cognitive outcomes were reported by two follow-up studies from the same original 
cohort. Lucas et al(27) reported no significant differences in the VIQ, PIQ and FSIQ at 7.5- 8 
years of age between the intervention and control groups in both the sole diet trial and the 
supplementation trial. In contrast, Isaac et al(25) found that the mean±SD VIQ at the median 
age of 16 years was significantly higher in the intervention group compared to the control 










This article is protected by copyright. All rights reserved. 
Rate of survival without neurodevelopmental impairment:  
Meta-analyses of the rate of survival without neurodevelopmental impairment were carried 
out on four EN(9, 10, 26, 34, 41) and four PN(20, 21, 23, 34) studies. Meta-analyses 
revealed that infants who received increased EN were approximately twice as likely to 
survive without neurodevelopmental impairment compared to the infants who received a 
standard amount of nutrition, OR 1.89 (1.24, 2.73; p= 0.003). No difference was found on 
meta-analysis of PN studies, OR 1.04 (0.74, 1.46; p= 0.82), as demonstrated in figure 6. Of 
note, one RCT(10) reported the incidence of MDI < 70 and PDI < 70 seperately, rather than 
the number of infants with neurodevelopmental impairment (defined as either MDI or PDI 
being less than 70). Therefore, in order to be included in the meta-analysis, the total number 
of infants with either MDI < 70 and PDI < 70 were combined to give a total number of infants 
with impairment, though the actual number of infants with neurodevelopmental impairment 
may be overestimated in comparison to the other included studies, as some infants with both 
a MDI < 70 and PDI < 70 will have been double counted. 
 
Secondary outcomes   
Neurological outcome 
Four RCTs and two observational studies reported the rate of CP. Meta-analyses of two EN 
trials(27, 28), four PN trials(19-21, 23), and two sole diet trials(12,28) showed no significant 
difference in incidence of CP, with OR of 0.84 (0.44, 1.6; p = 0.59),1.06 (0.68, 1.63; p = 
0.66) and 1.6 (0.56, 4.55), respectively. 
Rate of neurodevelopmental impairment at toddler age: Results of meta-analysis  
Definitions of neurodevelopmental impairment differed across studies. Meta-analysis of 
three PN trials(20, 21, 23) (which defined impairment as at least one of the following: MDI or 
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rates of neurodevelopmental impairment at 18-24 months with an OR of 1.10 (0.78, 1.56; p= 
0.58).  
Rate of neurodevelopmental impairment: Results not included in meta-analysis  
Of the remaining studies that reported neurodevelopmental impairment(9, 10, 26, 27, 29), 
only one RCT, Lucas et al 1990(10), and its follow-up(27), reported a significantly higher 
incidence in the group that received standard nutrition, with a significantly lower incidence of 
psychomotor impairment (defined as PDI < 86) in the group that received increased nutrition 
at 18 months. The follow-up study also reported a significantly lower rate of cognitive 
impairment (VIQ < 85) at 7.5-8 years in a combined cohort of infants that received either 
increased EN via sole diet or supplementation. This remained statistically significant after 
adjusting for CP(27).  
 
DISCUSSION  
This review found that increased PN, particularly increased amino acid intake in the early 
period after birth, may result in sub-optimal neurodevelopmental outcomes at 24 months 
CGA. However, only two studies could be pooled in the meta-analysis (figure 5) due to the 
variation in outcomes measures and data reporting, therefore this finding requires 
confirmation through further research. On the other hand, importantly, the review also 
suggests that increased enteral nutrition may result in increased numbers of very preterm 
and/or very low birthweight infants surviving without neurodevelopmental impairment. A 
speculative explanation for such findings is that the omission of infants who did not survive 
for neurodevelopmental assessment and were thus omitted from the meta-analyses, may 
have confounded the results. By including survival in the outcome as ‘survival without 
neurodevelopmental impairment’, we were able to adjust for this possible confounding effect, 
and have shown that higher PN intake does not increase the likelihood of 
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from early increased amino acid intake seen in Blanco et al’s study, it is important to 
consider that this could be related to the specific composition of the amino acid solution, 
rather than to overall intake of protein. Therefore, findings from this study may not be 
generalisable to other studies with early increased amino acid interventions. Additionally, 
this study has a high attrition rate with the fewest participants (n = 16) in the meta-analysis at 
24 months. Overall, our review showed no significant effects from increased nutrition on the 
rates of CP. 
Meta-regression did not provide additional information on the relationship between nutritional 
intake and neurodevelopment, but individual studies from this review have demonstrated 
significant associations. In a retrospective observational study which investigated increased 
parenteral nutrition via multi-nutrient intervention, Cormack et al(24), found that mean 
enteral protein intake during the first two postnatal weeks had a positive association with 
cognitive (r2= 0.13, p = 0.03) and motor subscales (r2= 0.27, p = 0.001) of Bayley III at 18 
months CGA. Similarly, Stephens et al(42) reported a positive association between average 
energy and protein intake in the first week after birth and MDI at 18 months CGA. In 
addition, nutritional deficits at 28 days after birth were found to be negatively associated with 
neurodevelopment at 3 months. Tan et al (32) calculated energy and protein deficit at 28 
days after birth by subtracting actual daily intakes from recommended intakes of 120 
kcal/kg/day of energy and 3 g/kg/day of protein. Energy and protein deficit significantly 
correlated with MDI (R = -20.25, p = 0.03 and R= -20.32, p = 0.004, respectively), and PDI 
(R= -20.29, p = 0.01 and R= -20.3, p = 0.006, respectively) 
Longer term outcome was reported in two studies of the same RCT cohort, but with 
inconclusive findings(25, 27). Lucas et al(27) reported a small, but non-significant, 
advantage in VIQ and PIQ at 7.5-8 years of age in the multi-nutrient supplementation trial, 
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nutrient group. However, the reported confidence interval was contradictory to the p-value 
(CI: -14, 12; p < 0.01), thus the significance is unclear.  
Although our review has not specifically explored the effects of gender, several studies have 
suggested that early increased nutrition may have greater beneficial effects on premature 
boys than girls. Van den Akker et al demonstrated that preterm male infants are six times 
more likely to have normal outcomes with parenteral nutritional intervention compared to 
preterm female infants [adjusted odds ratio = 6.17, 95% CI (1.01 – 38.46)]. This was similar 
to the studies by Lucas et al, who observed greater impact of increased early enteral 
nutrition on neurodevelopment in male than female preterm infants throughout their series of 
RCTs and follow-up studies. Substantial effects from enteral supplementation on mental and 
motor development in males compared to females were found particularly at the 18 month 
CGA follow-up. Brain development is different between male and female, and it has been 
suggested that this may influence the periods of maximal sensitivity to environmental factors 
such as nutrition.   
Significant heterogeneity was found across the meta-analyses. The meta-analysis for PN 
trials and MDI at 12-18 months showed significant heterogeneity (I2 = 75.9%) between the 
study designs. The only RCT that was pooled into this meta-analysis demonstrated 
significant negative findings within the subgroup analysis, however, this study included the 
smallest sample size and when combined with observational studies, the mean difference 
became statistically non-significant. Similarly, meta-analysis of EN studies and PDI at 12-18 
months CGA showed I2 = 95%, where significant benefits were described by two of the five 
studies, with Lucas et al(10) reporting the greatest effect. Although this study (10) was 
assessed to contain low risk of bias, it was conducted more than two decades ago, and 
further studies in a more contemporary sample may strengthen the evidence for the 
conclusion made in this study. Likewise, the reviewed literature is dominated by research 
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this topic. Recent trials that were included were predominately single centered. Results of 
larger multi-centered studies investigating neurodevelopmental outcome as a primary or 
secondary outcome are not currently available.  
A considerable amount of variation in the type of interventions, outcomes, and age at 
assessment was found across the studies, particularly in the EN trials. The components of 
nutritional interventions differed markedly between studies. The proportion of mother’s 
breast milk and supplementation used in individual trials was also not controlled except in 
one of the supplement trials(9). Consequently, the actual effect of increased nutrition might 
not be fully reflected in these studies. Another major limitation in the data is that not all the 
studies reported whether the actual nutritional intervention was achieved, and for the 11 
studies that have reported this, only 4 studies achieved the intended nutrient intakes.  
While this review supports the concept that early nutrition is important for optimal neuro-
development, it provides no clarity on which specific nutrients or clusters of nutrients might 
be beneficial – or potentially harmful. Furthermore, the recommended nutritional intakes for 
preterm infants have changed over the last two decades, and this is demonstrated by the 
significant variations between the nutrition interventions in studies published at different 
times over the past 20 years or so (see table S1). The older studies appear to provide 
smaller amounts of nutrition in their control groups compared to more recent studies. When 
the standard nutrition is below optimal, providing more nutrition may be beneficial; however, 
providing nutrition above the optimal level may not be beneficial and may even be harmful.  
Nutrition is complex and it is likely that there is a pattern of optimal intake of multiple 
nutrients, including energy, amino acids and micro-nutrients, which must be balanced with 
metabolic capacity. Including neurodevelopment as an outcome measure to identify these 
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intrauterine toxins and infections, maternal co-morbidities, genetic factors and many other 
variables could not be considered in this review. 
 
CONCLUSION 
This study provides a comprehensive review of the published evidence for the effects of 
increased early nutrition, either via increased macronutrients or multi-nutritional intervention, 
on neurodevelopmental outcome in VP and/or VLBW infants at toddler age and in childhood. 
The review has shown that increased early nutrition may increase the likelihood of survival 
without neurodevelopmental impairment in VP and/or VLBW infants, but the direct 
relationship between neurodevelopmental outcome and nutrition after birth remains unclear. 
Whilst early nutritional interventions may be beneficial for neurodevelopment, optimal 
nutritional regimens are still not defined, and as such there is a need for additional research 
in this field. Further research should follow the Core Outcome Measures in Effectiveness 
Trials initiative(43) to develop a core set of agreed standardised outcomes. This will facilitate 
data synthesis for future systematic reviews, as the lack of homogeneity was a major 
limitation in this review.  
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Bayley III- Bayley Scales of Infant and Toddler Development - Third edition 
BSID II- Bayley Scales of Infant Development - Second edition 
BW- birth weight 
CGA- corrected gestational age 
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CP- cerebral palsy 
ELBW- extremely low birth weight 
EN- enteral nutrition 
FSIQ- Full Scale Intelligence Quotient 
GA- gestational age 
GMDS- Griffiths Mental Development Scales 
IVH- intraventricular haemorrhage 
MDI- Mental Developmental Index 
MFED- Munich Functional Developmental Diagnostic test 
NEC- necrotising enterocolitis 
NRCT- non randomised controlled trial 
OR- odds ratio 
PDI- Psychomotor Developmental Index 
PIQ- Performance Intelligence Quotient 
PN- parenteral nutrition 
RCT- randomised controlled trial 
SD- standard deviation 
VIQ- Verbal Intelligence Quotient 
VLBW- very low birth weight 
VP- very preterm 
WAIS-R- Wechsler Adult Intelligence Scale-Revised 
WISC-III- Wechsler Intelligence Scale for Children - Third edition 
WISC-R- Wechsler Intelligence Scale for Children - Revised 
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 Search terms 
 
1 
exp Infant, Very Low Birth Weight/ or exp 
Infant, Newborn/ or exp Infant, Premature/ 
or exp Infant, Extremely Low Birth Weight/ 
2 preterm*.mp.  
3 prematur*.mp.  
4 neonat*.mp. 
5 1 or 2 or 3 or 4 
6 exp Nutrition Therapy/ or exp Enteral 
Nutrition/ or exp Parenteral Nutrition, Total/ 
or nutrition*.mp. or exp Parenteral 
Nutrition/ 
7 exp Child Development/ 
8 exp Neurologic Examination/ 
9 (cerebral adj palsy).mp. 




14 (mental adj development).mp. 
15 (psychomotor adj development).mp. 
16 (motor adj scales).mp 
17 (language adj scales).mp. 
18 (cognitive adj scales).mp 
19 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 
15 or 16 or 17 or 18 
20 5 and 6 and 19 
21 limit 20 to Humans 
Table 1: Search terms and strategy used for electronic searches1 
1Performed by using OvidSp (Wolters Kluwer Health; http://www.ovid.com). adj, 
adjacent to; exp, exploded Medical Subject Headings term; .mp.,multipurpose search 
across the fields title, abstract, subject headings, heading word, drug trade name, 













































Control Intervention Control 
Lucas1996(8)
 
RCT EN 137 138 29.8 1285 Multinutrient supplement to MBM* Control supplement to MBM* 48-72 hrs 39d 
Lucas 1989a(9)
 
RCT EN 76 83 31.2 1378 PTF sole diet* DBM sole diet* <48 hrs 30d 
Lucas 1989b(9)
 
RCT EN 173 170 30.8 1386 PTF supplement to MBM* DBM supplement to MBM* <48 hrs 30d 
Lucas 1994a(28)
 
FU EN 76 83 31.3 1400 PTF sole diet* DBM sole diet* <48 hrs 30d 
Lucas 1994b(28)
 
FU EN 173 170 31.1 1388 PTF supplement to MBM* DBM supplement to MBM* <48 hrs 30d 
Lucas 1990a(10)
 
RCT EN 81 79 30.8 1372 PTF sole diet* Term formula sole diet* <48 hrs 28d 
Lucas 1990b(10)
 
RCT EN 132 132 31.2 1427 PTF supplement to MBM* Term formula supplement to MBM* <48 hrs 28d 
Lucas 1998a(27)
 
FU EN 67 68 30.8 1379 PTF sole diet* Term formula sole diet* <48 hrs 28d 
Lucas 1998b(27)
 
FU EN 112 113 31.3 1425 PTF supplement to MBM* Term formula supplement to MBM* <48 hrs 28d 
Isaacs 2008(25)
 
FU EN 38 38 28.7 1216 PTF supplement to MBM* Term formula supplement to MBM* <48 hrs 28d 
Tan 2008(32)
 
RCT Both 68 74 26.1 913 Hyperalimentated diet* Control diet* <7d 7d 
Biasini 2012(29)
 
RCT EN 19 13 28.1 976 
Protein enriched supplement to 
MBM* 
Control supplement to MBM* At full EN  34d 
Blanco 2012(19)
 
RCT PN 30 31 26.4 813 2g/1g until 4g Protein in PN 0.5g/0.5g until 3g Protein in PN 24-36 hours 7d 
Ergenekon 2012(30)
 
RCT EN 33 32 30.3 1361 
Protein supplement to fortified 
MBM/PTF* 
Control supplement to fortified 
MBM/PTF* 
At full EN Unknown 
Svenningsen 1982(31)
 
RCT EN 16 18 30.6 1348 Protein enriched formula* Control formula* Soon After birth 28d 
Kocourkova 2004(26)
 
NRCT EN 22 17 30.8 1307 Fortified DBM* MBM* <7d 56d 
Cormack 2011(24) Obs PN 49 40 27 920 
Reformulated nutrient enriched 
PN* 
Previous PN* Soon After birth 7d 
Poindexter 2006(21)
 
Obs PN 182 836 26.1 798 >3.5g/kg/d Protein PN <3.5g/kg/d Protein PN After birth 5d 
Karakus 2010(20)
 
Obs PN 31 45 29.2 1146 1g/1g until 3.5-4g Protein in PN 0.5g/0.5g until 3.5g Protein in PN Day 2 5d 
Rochow 2012(22) Obs Both 123 115 28.9 1070 After feeding implementation* Before feeding implementation* From birth 
Approx. 7 wks 
(intervention until 
36 wk PMA) 
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Table 2. Characteristics of included studies; EN: enteral nutrition, PN: parenteral nutrition, RCT: randomised controlled trial, FU: Follow Up study, NRCT: non 
randomised controlled trial, Obs: Observational Study, MBM: maternal breast milk, DBM: donor breast milk, PTF: preterm formula, d: day; PMA: Post 
Menstrual Age 









van den Akker 
2014(23) 
RCT PN 66 69 28.4 1014 
Glucose + 2.4g/kg/d (from 2 hours 
to d3  
Glucose + 1.2g/kg/d increased to 
2.4g/kg/d 24 hours later until d 3 

















Lucas 1996(8) low low low low low low 
Lucas 1989(9) low low high low low low 
Lucas 1994(28) low low high low low moderate 
Lucas 1990(10) low low low low low low 
Lucas 1998(27) low low low low low low 
Isaacs et al 2008(25) unclear low low low low low 
Tan 2008(32) low low high high low low 
Biasini 2012(29) unclear unclear unclear unclear unclear low 
Blanco 2012(19) low low unclear low low low 
Ergenekon 2012(30) unclear unclear unclear unclear unclear unclear 
Svenningsen 1982(31) unclear low unclear unclear unclear unclear 
Kocourkova 2004(26) low high high unclear unclear Low 
Burattini 2013(34) low low high low low Low 
Van Den Akker(23) unclear unclear low unclear low low 
 
Table 3A. The level of apparent bias in included RCTs as assessed using the Cochrane risk of bias assessment tool   
1. Selection bias due to inadequate generation of a randomised sequence. 
2. Selection bias due to inadequate concealment of allocation prior to assignment. 
3. Performance bias due to knowledge of the allocated interventions by personnel during the study. 
4. Detection bias due to knowledge of the allocated interventions by outcome assessors. 
5. Attrition bias due to the amount, nature or handling of incomplete data. 


















































Cormack 2011(24)  +    +    +    +   + -  +    +   
Poindexter 2006(21)   +    +   + -  +   +  +    +   
Karakus 2010 (20)  +    +   +  +   - -  +    +   
Rochow 2012 (22)  +  + +  + - -  +  - 
 
Table 3B.  Quality assessment of observational studies using Newcastle Ottawa Scale. 
1. Truly or somewhat representative (+) Selected group of user or no description (-) 
2. Drawn from same community as the exposed (+) Drawn from different source or no description(-) 
3. Secure record or structured interview(+) written self report or no description (-) 
4. Yes (+) No (-) 
5. Controls for baseline weight (+) controls for any factors (+) Does not control for any factor (-) 
6. Independent blind assessment or record linkage (+) self report or no description (-) 




































































Figure 1. Flow chart of review process 
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database searching  
(n = 4300) 
Additional records identified 
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Review articles (n= 13) 
 
Specific nutrient intervention 
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No increase nutritional 
intervention (n= 4) 
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Figure 2: Forest plots for meta-analyses of differences in (a) MDI and (b) PDI scores 
at 12-18 months between VP and/ or VLBW infants received increased or standard 


















Figure 3: Forest plots for meta-analyses of differences in (a) MDI and (b) PDI scores 
at 12-18 months between VP and/ or VLBW infants received increased or standard 
















Figure 4: Forest plots for meta-analyses of differences in (a) MDI and (b) PDI scores 
at 12-18 months between VP and/ or VLBW infants received increased or standard 






Figure 5: Forest plots for meta-analyses of differences in (a) MDI and (b) PDI scores 
at 24 months between VP and/ or VLBW infants received increased or standard 















Figure 6: Forest plots for meta-analyses of differences in the survived infants without 
neurodevelopmental impairment in (a) enteral nutrition studies and (b) parenteral 
nutrition studies 
 
